0 CHECKOUT

Hematological Tumor Global Clinical Trials Review, H1, 2015

  • ID: 3161779
  • March 2015
  • Region: Global
  • 102 pages
  • GlobalData
1 of 3

Hematological Tumor Global Clinical Trials Review, H1, 2015

Summary

Our clinical trial report, “Hematological Tumor Global Clinical Trials Review, H1, 2015" provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematological Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and READ MORE >

Note: Product cover images may vary from those shown
2 of 3

List of Tables
List of Figures
Introduction
Hematological Tumor
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Hematological Tumor to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hematological Tumor to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Hematological Tumor
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hematological Tumor Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Novartis AG
Clinical Trial Overview of Novartis AG
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Infinity Pharmaceuticals, Inc.
Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
Sanofi
Clinical Trial Overview of Sanofi
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Bellicum Pharmaceuticals, Inc.
Clinical Trial Overview of Bellicum Pharmaceuticals, Inc.
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Thomas Jefferson University
Clinical Trial Overview of Thomas Jefferson University
Baylor College of Medicine
Clinical Trial Overview of Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
National Cancer Center Hospital
Clinical Trial Overview of National Cancer Center Hospital
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Hematological Tumor Therapeutics, Global, Clinical Trials by Region, 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015-
Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015-
Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2015-
Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries, 2015-
Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015-
Hematological Tumor Therapeutics Clinical Trials, Central and South America, Top Countries, 2015-
Proportion of Hematological Tumor to Oncology Clinical Trials, G7 Countries (%), 2015-
Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2015-
Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015-
Proportion of Hematological Tumor to Oncology Clinical Trials, E7 Countries (%), 2015-
Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Phase, 2015-
Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials by Phase, 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Phase 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2015-
Hematological Tumor Therapeutics, Global, Suspended Clinical Trials, 2015-
Hematological Tumor Therapeutics, Global, Withdrawn Clinical Trials, 2015-
Hematological Tumor Therapeutics, Global, Terminated Clinical Trials, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Bellicum Pharmaceuticals, Inc., 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2015-
Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015-

List of Figures
Hematological Tumor Therapeutics, Global, Clinical Trials by Region (%), 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015-
Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015-
Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015-
Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2015-
Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015-
Hematological Tumor Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015-
Proportion of Hematological Tumor to Oncology Clinical Trials, G7 Countries (%), 2015-
Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2015-
Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015-
Proportion of Hematological Tumor to Oncology Clinical Trials, E7 Countries (%), 2015-
Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Phase, 2015-
Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials by Phase (%), 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Phase, 2015-
Hematological Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015-
Hematological Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015-
GlobalData Methodology

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Photocure ASA
  • Roche Diagnostics Ltd.
  • Abbott Laboratories Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Becton, Dickinson and Company (BD)